Zinc(II) sensitive MRI contrast agents as diagnostic sensors for tracking insulin secretion

Ended Project Grant Awarded Last action

Award ID
R44DK113831
Recipient
Awarding agency
Obligated
$1,526,937

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Originally
Place of performance
Dallas, TX 75235, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$291
Amendment -$19,935
Amendment $19,935
Amendment $19,935
Amendment -$19,935
Amendment -$19,935
Amendment -$103,674
Amendment $103,674
Amendment -$103,674
Amendment $103,674
Amendment -$103,674
Amendment $103,674
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $710,902
Amendment $103,674
Amendment -$103,674
Amendment $655,411
Amendment $0
Original award $180,850
Show all 23

Quick answers

Who received award R44DK113831?

R44DK113831 was awarded to Vitalquan LIMITED Liability Company by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on August 1, 2017.

How much is award R44DK113831 worth?

$1,526,937 has been obligated on R44DK113831.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award